A comparison of five different drug-drug interaction checkers for selective serotonin reuptake inhibitors
BackgroundSelective serotonin reuptake inhibitors (SSRIs) are widely prescribed for depression and anxiety, but their potential for drug-drug interactions (DDIs) poses significant risks, particularly given their influence on cytochrome P450 enzymes. Variability in identifying and classifying these i...
| Published in: | Frontiers in Pharmacology |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-09-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1690975/full |
